BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

被引：0

作者：

Knebelmann, Bertrand ^{[1
]}

Appel, Gerald ^{[2
]}

Block, Geoffrey ^{[3
]}

Chin, Melanie ^{[3
]}

Goldsberry, Angie ^{[3
]}

Inker, Lesley ^{[4
]}

Kashtan, Clifford ^{[5
]}

Meyer, Colin ^{[3
]}

Nozu, Kandai ^{[6
]}

Pergola, Pablo ^{[7
]}

Rastogi, Anjay ^{[8
]}

Rheault, Michelle ^{[5
]}

Silva, Arnold ^{[9
]}

Sprague, Stuart ^{[10
]}

Warady, Bradley ^{[11
]}

Gross, Oliver ^{[12
]}

机构：

[1] Hop Necker Enfants Malad, Paris, France

[2] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA

[3] Reata Pharmaceut Inc, Irving, TX USA

[4] Tufts Univ, Boston, MA 02111 USA

[5] Univ Minnesota, Minneapolis, MN USA

[6] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan

[7] Renal Associates, San Antonio, TX USA

[8] Univ Calif Los Angeles, Los Angeles, CA USA

[9] Boise Kidney & Hypertens Inst, Meridian, ID USA

[10] NorthShore Univ HealthSyst, Evanston, IL USA

[11] Univ Missour Kansas City, Sch Med, Kansas City, MO USA

[12] Univ Gottingen, Gottingen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

FP179

引用

页码：104 / 104

页数：1

共 50 条

[1] Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Chertow, Glenn M.
Appel, Gerald B.
Andreoli, Sharon
Bangalore, Sripal
Block, Geoffrey A.
Chapman, Arlene B.
Chin, Melanie P.
Gibson, Keisha L.
Goldsberry, Angie
Iijima, Kazumoto
Inker, Lesley A.
Knebelmann, Bertrand
Mariani, Laura H.
Meyer, Colin J.
Nozu, Kandai
O'Grady, Megan
Silva, Arnold L.
Stenvinkel, Peter
Torra, Roser
Warady, Bradley A.
Pergola, Pablo E.
AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (03) : 180 - 189
[2] SAFETY OF BARDOXOLONE METHYL IN PEDIATRIC PATIENTS WITH ALPORT SYNDROME IN CARDINAL PHASE 3 TRIAL
Warady, Bradley
Chadha, Vimal
Chin, Melanie
Gbadagesin, Rasheed A.
Gibson, Keisha
Gipson, Debbie
Goldsberry, Angie
Lieberman, Kenneth
Meyer, Colin
Meyers, Kevin
Nozu, Kandai
O'Grady, Megan
Rheault, Michelle
Kashtan, Clifford
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
[3] A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Gross, Oliver
Appel, Gerald
Block, Geoffrey
Chin, Melanie
Goldsberry, Angie
Inker, Lesley
Meyer, Colin
Pergola, Pablo
Simon, James
Warady, Bradley
Zaoui, Phillip
Rheault, Michelle
Kashtan, Clifford
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
[4] A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Meyer, Colin
Warnock, David
Chin, Melanie
Goldsberry, Angie
McCullough, Peter
O'Grady, Megan
Toto, Robert
Ward, Keith
Block, Geoffrey
Pergola, Pablo
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 480 - 480
[5] Integrated Analysis of the Efficacy and Safety of Bardoxolone Methyl in Patients with Alport Syndrome
Warady, Bradley A.
Agarwal, Rajiv
Andreoli, Sharon P.
Bangalore, Sripal
Block, Geoffrey A.
Chapman, Arlene B.
Chin, Melanie
Devarajan, Prasad
Gibson, Keisha L.
Goldsberry, Angie
Mariani, Laura H.
Meyer, Colin J.
O'Grady, Megan
Stenvinkel, Peter
Chertow, Glenn M.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 417 - 418
[6] THE CARDINAL TRIAL OF BARDOXOLONE METHYL IN ALPORT SYNDROME: WHEN MARKETING INTERESTS PREVAIL OVER PATIENTS CLINICAL NEEDS
Ruggenenti, Piero
NEPHRON, 2023, 147 (08) : 465 - 469
[7] Patient Global Impression of Change in Patients with Alport Syndrome in the CARDINAL Phase 3 Trial
Chertow, Glenn M.
Pergola, Pablo E.
Agarwal, Rajiv
Andreoli, Sharon P.
Appel, Gerald B.
Bangalore, Sripal
Block, Geoffrey A.
Chin, Melanie
Gibson, Keisha L.
Goldsberry, Angie
Iijima, Kazumoto
Inker, Lesley A.
Kashtan, Clifford E.
Knebelmann, Bertrand
Mariani, Laura H.
Meyer, Colin J.
Nozu, Kandai
O'Grady, Megan
Silva, Arnold L.
Stenvinkel, Peter
Torra, Roser
Warady, Bradley A.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 418 - 418
[8] A PHASE 2 TRIAL OF THE SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH RARE CHRONIC KIDNEY DISEASES
Pergola, Pablo
Appel, Gerald
Block, Geoffrey
Chin, Melanie
Goldsberry, Angie
Inker, Lesley
Jarad, George
Meyer, Colin
Rastogi, Anjay
Rizk, Dana
Silva, Arnold
Warnock, David
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
[9] Interim Analysis of the EAGLE Trial: An Open-Label Study to Assess the Long-Term Safety and Tolerability of Bardoxolone Methyl in Patients with Alport Syndrome
Pergola, Pablo E.
Appel, Gerald B.
Chin, Melanie
Fischbach, Bernard V.
Knebelmann, Bertrand
Lieberman, Kenneth V.
Meyer, Colin J.
Nozu, Kandai
Packham, David K.
Rizk, Dana
Silva, Arnold L.
Spinowitz, Bruce S.
Sprague, Stuart M.
Torra, Roser
Zaoui, Philippe
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 417 - 417
[10] SAFETY AND EFFICACY OF BARDOXOLONE METHYL IN PATIENTS WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Pergola, Pablo
Acharya, Anjali
Awad, Ahmed
Block, Geoffrey
Chin, Melanie
Goldsberry, Angie
Meyer, Colin
Schroeder, Kevin
Silva, Arnold
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34

← 1 2 3 4 5 →